Cawachi Ltd

Cawachi Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.15, indicating a low reliance on debt financing. The company's liquidity position is supported by a current ratio of 1.37, suggesting it can meet short-term obligations comfortably. With cash and equivalents amounting to 34,977 million JPY, the company has a strong liquidity buffer.

Profitability metrics for Cawachi Ltd show a return on equity (ROE) of 1.07% and a return on assets (ROA) of 0.59%, both of which are below the typical thresholds for high-performing firms in the drug retailing industry. The company's operating income of 1,560 million JPY and net income of 1,181 million JPY reflect modest profitability, with gross profit of 16,341 million JPY indicating a relatively narrow margin structure.

Geographically and segment-wise, the company's revenue is concentrated within Japan, as disclosed in its financial reports. There is no detailed breakdown of revenue by business segment, but the company's primary operations are centered on drug retailing. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to Japan.

Looking ahead, the company's revenue is expected to grow, supported by its market position and operational scale. However, the exact growth rate is not specified in the available data. The company's historical revenue of 71,336 million JPY provides a baseline for assessing future performance.

Risk factors for Cawachi Ltd include low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves mitigate credit risk. However, the company's profitability metrics suggest that it may face challenges in maintaining or improving returns in a competitive market.

Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's financial performance remains stable, with no major disruptions reported in the latest disclosures.

Revenue ¥284.49B, −1,1% YoY; Operating income −25,8% YoY.

• ▍Revenue ¥284.49B, −1,1% YoY
• ▍Operating income −25,8% YoY
• ▍Net income −34,5% YoY
• ▍Free cash flow −53,0% YoY
• ▍Net margin 1.1%

Revenue ¥287.82B, +0,7% YoY; Operating income −3,8% YoY.

• ▍Revenue ¥287.82B, +0,7% YoY
• ▍Operating income −3,8% YoY
• ▍Net income +3,6% YoY
• ▍Free cash flow +32,0% YoY
• ▍Net margin 1.7%

Revenue ¥285.96B, +1,4% YoY; Operating income +11,5% YoY.

• ▍Revenue ¥285.96B, +1,4% YoY
• ▍Operating income +11,5% YoY
• ▍Net income +12,8% YoY
• ▍Free cash flow +48,0% YoY
• ▍Net margin 1.6%

Revenue ¥281.87B, +0,9% YoY; Operating income −18,1% YoY.

• ▍Revenue ¥281.87B, +0,9% YoY
• ▍Operating income −18,1% YoY
• ▍Net income −13,5% YoY
• ▍Free cash flow −53,2% YoY
• ▍Net margin 1.5%

Revenue ¥279.46B; Operating income ¥6.65B.

• ▍Revenue ¥279.46B
• ▍Operating income ¥6.65B
• ▍Net margin 1.7%